Login / Signup

Toxic Advanced Glycation End Product-Dependent Alzheimer's Disease- Like Alternation in the Microtubule System.

Hayahide OoiYoshiki Koriyama
Published in: Current Alzheimer research (2024)
Type 2 diabetes mellitus (T2DM) is a risk factor for Alzheimer's Disease (AD). However, the detailed mechanism underlying T2DM-related AD remains unknown. In DM, many types of advanced glycation end products (AGEs) are formed and accumulated. In our previous study, we demonstrated that Glyceraldehyde (GA)-derived toxic Advanced Glycation End products (toxic AGEs, TAGE) strongly showed cytotoxicity against neurons and induced similar alterations to those observed in AD. Further, GA induced dysfunctional neurite outgrowth via TAGE-β-tubulin aggregation, which resulted in the TAGE-dependent abnormal aggregation of β-tubulin and tau phosphorylation. Herein, we provide a perspective on the possibility that T2DM increases the probability of AD onset and accelerates its progression.
Keyphrases
  • pet ct
  • glycemic control
  • high glucose
  • diabetic rats
  • cognitive decline
  • spinal cord
  • endothelial cells
  • metabolic syndrome
  • spinal cord injury
  • oxidative stress
  • cardiovascular disease
  • skeletal muscle